JGUA
CBST

John G. Ullman & Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

John G. Ullman & Associates’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,100
Closed -$1.42M – 150
2014
Q4 		$1.42M Sell
14,100
-70
-0.5% -$5.44K 0.27% 88
2014
Q3 		$940K Sell
14,170
-455
-3% -$29.9K 0.18% 110
2014
Q2 		$1.02M Sell
14,625
-450
-3% -$30.6K 0.19% 106
2014
Q1 		$1.1M Sell
15,075
-2,380
-14% -$177K 0.2% 99
2013
Q4 		$1.2M Sell
17,455
-1,450
-8% -$93.9K 0.23% 99
2013
Q3 		$1.2M Sell
18,905
-2,325
-11% -$141K 0.24% 97
2013
Q2 		$1.02M Buy
+21,230
New +$1.04M 0.21% 98

John G. Ullman & Associates's CBST Position: Q1 2015 in Review

John G. Ullman & Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 14,100 shares — an estimated $1.42M sold.

John G. Ullman & Associates first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $1.42M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • John G. Ullman & Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • John G. Ullman & Associates sold 14,100 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.42M.
  • John G. Ullman & Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • John G. Ullman & Associates's CUBIST PHARMACEUTICALS INC position peaked at $1.42M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on John G. Ullman & Associates's 13F filing for Q1 2015, filed 13 May 2015.